"Salvage Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.
| Descriptor ID |
D016879
|
| MeSH Number(s) |
E02.895
|
| Concept/Terms |
Salvage Therapy- Salvage Therapy
- Salvage Treatment
- Salvage Treatments
- Treatment, Salvage
- Treatments, Salvage
- Therapy, Salvage
- Salvage Therapies
- Therapies, Salvage
|
Below are MeSH descriptors whose meaning is more general than "Salvage Therapy".
Below are MeSH descriptors whose meaning is more specific than "Salvage Therapy".
This graph shows the total number of publications written about "Salvage Therapy" by people in this website by year, and whether "Salvage Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 4 | 5 |
| 1997 | 0 | 3 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 8 | 11 |
| 2004 | 3 | 4 | 7 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 3 | 4 |
| 2007 | 5 | 3 | 8 |
| 2008 | 5 | 3 | 8 |
| 2009 | 1 | 4 | 5 |
| 2010 | 8 | 6 | 14 |
| 2011 | 2 | 2 | 4 |
| 2012 | 4 | 2 | 6 |
| 2013 | 1 | 4 | 5 |
| 2014 | 4 | 3 | 7 |
| 2015 | 3 | 4 | 7 |
| 2016 | 5 | 1 | 6 |
| 2017 | 9 | 2 | 11 |
| 2018 | 3 | 5 | 8 |
| 2019 | 4 | 4 | 8 |
| 2020 | 5 | 4 | 9 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salvage Therapy" by people in Profiles.
-
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. Urol Oncol. 2025 Mar; 43(3):135-146.
-
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database. Radiother Oncol. 2024 Dec; 201:110532.
-
The Neurostimulation Appropriateness Consensus Committee (NACC)®: Recommendations for Spinal Cord Stimulation Long-Term Outcome Optimization and Salvage Therapy. Neuromodulation. 2024 Aug; 27(6):951-976.
-
A nationwide analysis of salvage surgery for laryngeal cancer in the elderly. Head Neck. 2023 11; 45(11):2915-2924.
-
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia. 2023 04; 37(4):799-806.
-
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. J Clin Oncol. 2023 02 20; 41(6):1307-1317.
-
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply. Lancet. 2022 09 17; 400(10356):885-886.
-
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. Lancet. 2022 05 14; 399(10338):1886-1901.
-
Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022 Mar-Apr; 48(2):263-274.
-
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. N Engl J Med. 2022 02 17; 386(7):629-639.